SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001745020-23-000075
Filing Date
2023-11-15
Accepted
2023-11-15 07:00:17
Documents
2
Period of Report
2023-09-30
Effectiveness Date
2023-11-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q thrx-12bx25q310xqnovember2.htm NT 10-Q 21452
2 image_0.jpg GRAPHIC 2016
  Complete submission text file 0001745020-23-000075.txt   22847
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-40869 | Film No.: 231409006
SIC: 2834 Pharmaceutical Preparations